Magdalena Plebanski
Magdalena Plebanski
RMIT University (current)
Verified email at monash.edu
Title
Cited by
Cited by
Year
Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells
BC Urban, DJP Ferguson, A Pain, N Willcox, M Plebanski, JM Austyn, ...
Nature 400 (6739), 73-77, 1999
7041999
Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors
T Fifis, A Gamvrellis, B Crimeen-Irwin, GA Pietersz, J Li, PL Mottram, ...
The Journal of Immunology 173 (5), 3148-3154, 2004
6792004
Pathogen recognition and development of particulate vaccines: does size matter?
SD Xiang, A Scholzen, G Minigo, C David, V Apostolopoulos, PL Mottram, ...
Methods 40 (1), 1-9, 2006
5642006
Induction of peptide‐specific primary cytotoxic T lymphocyte responses from human peripheral blood
M Plebanski, CEM Allsopp, M Aidoo, H Reyburn, AVS Hill
European journal of immunology 25 (6), 1783-1787, 1995
4151995
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
R Daillère, M Vétizou, N Waldschmitt, T Yamazaki, C Isnard, ...
Immunity 45 (4), 931-943, 2016
3332016
Identification and characterization of three members of the human SR family of pre‐mRNA splicing factors.
GR Screaton, JF Caceres, A Mayeda, MV Bell, M Plebanski, DG Jackson, ...
The EMBO journal 14 (17), 4336-4349, 1995
3241995
A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease
WHH Reece, M Pinder, PK Gothard, P Milligan, K Bojang, T Doherty, ...
Nature medicine 10 (4), 406-410, 2004
3062004
Two-dimensional single-cell patterning with one cell per well driven by surface acoustic waves
DJ Collins, B Morahan, J Garcia-Bustos, C Doerig, M Plebanski, A Neild
Nature communications 6 (1), 1-11, 2015
3042015
Association of malaria parasite population structure, HLA, and immunological antagonism
SC Gilbert, M Plebanski, S Gupta, J Morris, M Cox, M Aidoo, ...
Science 279 (5354), 1173-1177, 1998
3031998
Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus
PL Mottram, D Leong, B Crimeen-Irwin, S Gloster, SD Xiang, J Meanger, ...
Molecular pharmaceutics 4 (1), 73-84, 2007
2732007
Induction of CD8+ T cells using heterologous prime‐boost immunisation strategies
J Schneider, SC Gilbert, CM Hannan, P Dégano, E Prieur, EG Sheu, ...
Immunological reviews 170 (1), 29-38, 1999
2431999
Vaccines that facilitate antigen entry into dendritic cells
A Gamvrellis, D Leong, JC Hanley, SD Xiang, P Mottram, M Plebanski
Immunology and cell biology 82 (5), 506-516, 2004
2242004
A protein particle vaccine containing multiple malaria epitopes
SC Gilbert, M Plebanski, SJ Harris, CEM Allsopp, R Thomas, GT Layton, ...
Nature biotechnology 15 (12), 1280-1284, 1997
2231997
Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime–boost immunisation regimes
SC Gilbert, J Schneider, CM Hannan, JT Hu, M Plebanski, R Sinden, ...
Vaccine 20 (7-8), 1039-1045, 2002
2212002
Potent induction of focused Th1-type cellular and humoral immune responses by RTS, S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine
A Lalvani, P Moris, G Voss, AA Pathan, KE Kester, R Brookes, E Lee, ...
The Journal of infectious diseases 180 (5), 1656-1664, 1999
2021999
IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling
S Li, MP Lefranc, JJ Miles, E Alamyar, V Giudicelli, P Duroux, JD Freeman, ...
Nature communications 4 (1), 1-13, 2013
1992013
Natural regulatory T cells and persistent viral infection
S Li, EJ Gowans, C Chougnet, M Plebanski, U Dittmer
Journal of virology 82 (1), 21-30, 2008
1852008
Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria
M Aidoo, A Lalvani, CEM Allsopp, M Plebanski, P Krausa, M Browning, ...
The Lancet 345 (8956), 1003-1007, 1995
1831995
Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]
V Apostolopoulos, GA Pietersz, A Tsibanis, A Tsikkinis, H Drakaki, ...
Breast Cancer Research 8 (3), 1-11, 2006
1752006
Paclitaxel and its evolving role in the management of ovarian cancer
NC Kampan, MT Madondo, OM McNally, M Quinn, M Plebanski
BioMed research international 2015, 2015
1742015
The system can't perform the operation now. Try again later.
Articles 1–20